These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 29124669)

  • 1. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.
    Philips CA; Kumar L; Augustine P
    Indian J Gastroenterol; 2017 Sep; 36(5):411-419. PubMed ID: 29124669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Maeda M; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol Hepatol; 2019 Jan; 34(1):215-223. PubMed ID: 30070412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Philips CA; Rajesh S; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2020 Aug; 39(4):377-387. PubMed ID: 32929684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
    Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
    Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A; Chalamarla LK; Singla N; Shasthry SM; Sarin SK
    Eur Radiol; 2020 Jun; 30(6):3462-3472. PubMed ID: 32048037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.
    Choudhary NS; Baijal SS; Saigal S; Agarwal A; Saraf N; Khandelwal R; Jain V; Khandelwal AH; Kapoor A; Jain D; Misra SR; Puri R; Sud R; Soin AS
    J Clin Exp Hepatol; 2017 Dec; 7(4):300-304. PubMed ID: 29234193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
    Lynn AM; Singh S; Congly SE; Khemani D; Johnson DH; Wiesner RH; Kamath PS; Andrews JC; Leise MD
    Liver Transpl; 2016 Jun; 22(6):723-31. PubMed ID: 26970243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial.
    Mukund A; Choudhury SP; Tripathy TP; Ananthashayana VH; Jagdish RK; Arora V; Singh SP; Mishra AK; Sarin SK
    Hepatol Int; 2023 Feb; 17(1):150-158. PubMed ID: 36094625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.
    Kako Y; Yamakado K; Jomoto W; Nasada T; Asada K; Takaki H; Kobayashi K; Daimon T; Hirota S
    Jpn J Radiol; 2017 Jul; 35(7):366-372. PubMed ID: 28501975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy secondary to intrahepatic portosystemic venous shunt: balloon-occluded retrograde transvenous embolization with n-butyl cyanoacrylate and microcoils.
    Yamagami T; Nakamura T; Iida S; Kato T; Tanaka O; Matsushima S; Ito H; Okuyama C; Ushijima Y; Shiga K; Nishimura T
    Cardiovasc Intervent Radiol; 2002; 25(3):219-21. PubMed ID: 12058220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
    Álvarez-López P; Campos-Varela I; Quiroga S; Díez I; Charco R; Simón-Talero M; Castells L
    Ann Hepatol; 2022; 27(3):100687. PubMed ID: 35192963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous use of plug-assisted and coil-assisted retrograde transvenous obliteration for treating refractory hepatic encephalopathy in a patient with two portosystemic shunts: A case report.
    Ju SG; Lee JM; Shim J
    Medicine (Baltimore); 2023 Jun; 102(22):e33961. PubMed ID: 37266629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy.
    An J; Kim KW; Han S; Lee J; Lim YS
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1418-26. PubMed ID: 24754260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis.
    Tanaka O; Ishihara K; Oyamada H; Harusato A; Yamaguchi T; Ozawa M; Nakano K; Yamagami T; Nishimura T
    J Vasc Interv Radiol; 2006 Dec; 17(12):1951-5. PubMed ID: 17185692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.